Leukemia Home > Oforta Discontinued

Adults who have B-cell chronic lymphocytic leukemia may receive Fludara® (fludarabine phosphate), a chemotherapy medication that is reserved for use when the cancer has progressed or not responded after other chemotherapy treatment. It is given as a daily injection into a vein (intravenously, or by IV) for 5 days in a row, every 28 days.
Ben Venue Laboratories for Genzyme Corporation manufactures brand-name Fludara. There are also generic versions of Fludara currently available, which are made by various manufacturers.
The active ingredient in Fludara, fludarabine phosphate, was previously available in tablet form. This medicine was called Oforta™. However, the manufacturer discontinued Oforta due to a lack of demand for the medication, and it is no longer available.
(Click Fludara for more details on this chemotherapy medication. This full-length article describes how the drug works, why it may not be suitable for some people, and more.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):



Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.